Lack of pharma transparency increases drug costs for everyone
Re MDs urge feds to open books on pharma-physician back-scratching, June 9 We applaud Dr. Andrew Boozary for lifting the lid on the practices of drug companies who curry favour with physicians.
Patients deserve to know if their health providers are receiving payments or other benefits in return for prescribing certain medications.
The lack of transparency is one of the reasons Canadians pay as much as 35 per cent more for prescription drugs than people in other industrialized countries in the Organization for Economic Co-operation and Development.
It also underscores the need for the federal government to play a larger role when it comes to ballooning drug expenditures.
Ontario has paved the way with its promise to provide everyone under the age of 25 with full drug coverage.
Imagine the benefits if the federal government provided universal coverage of medications in the same way it offers its citizens universal access to health care.
It would lead to lower drug prices and administrative costs through a single-payer approach, better health and budget outcomes through proper prescribing protocols and a value-formoney approach, and improved access to health care by providing drug coverage to millions of Canadians who don’t have it. Doris Grinspun, Chief Executive Officer, Registered Nurses’ Association of Ontario